Remove submit-story
article thumbnail

Unconventional Approaches Pharma Is Taking to Engage Patients

PM360

It started off with argenx employees reading letters written by the patient community about their struggles—MG patients no longer able to read bedtime stories to their daughter or dance at their son’s weeding or run their private psychiatry practice. The film can now be viewed on the unbranded site ShineALightonHS.com.

Patients 105
article thumbnail

12 Brilliant Healthcare Marketing Campaign Initiatives

Medico Reach

New York Presbyterian Hospital’s ‘Patient Stories’. Since such initiatives focus on individual stories, they serve as a reminder of how resilient the human spirit is. Moreover, besides promoting the profession, Johnson & Johnson also gave registered nursing professionals a platform to tell their stories.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Thursday pharma headlines

World of DTC Marketing

In order to use VAERS data to show the supposed dangers of vaccines, anti-vaccine groups have to avoid mentioning two crucial things: Anyone can submit a report to the program, and all of those data—unverified, unresearched, often anecdotal—are immediately available to the public. .

Pharma 180
article thumbnail

How Mental Health Clinics Automate Assessment Forms with Salesforce Health Cloud

Penrod

Here’s the story. This means that scoring no longer relies on manual calculation…rather, the final scores can be instantly submitted to the patient’s profile in Salesforce Health Cloud. Upon completion, forms can be submitted to seamlessly generate a new patient record in Salesforce Health Cloud.

article thumbnail

Research integrity: five tips for authors, editors and reviewers

Clarivate

The story behind unethical research. The retractions, for example this study published in The New England Journal of Medicine in 2020, resulted in widespread confusion and distrust in COVID-19 related research and even temporarily halted clinical trials of the use of the drug hydroxychloroquine in combating COVID-19.

Ethics 105
article thumbnail

Are timely access and robust safety mutually exclusive?

pharmaphorum

The FDA’s Breakthrough Designation and the EMA’s Priority Medicines and PRIME initiatives, for example, allow approvals to made on the basis of less comprehensive clinical data on the proviso that confirmatory data are submitted when they become available. Apart from Swissmedic, this is longer than other regulator,” said the report.

Safety 89
article thumbnail

Five top tips for advancing DEI in research environments

Clarivate

He shared a story of a gay researcher working on a project in Saudi Arabia. Having it in place from the beginning avoids submitting a tacked on, rush job that may sound more like lip service than a sincere commitment. #3 This prevents researchers from feeling so overwhelmed that they never create a DEI plan.